SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-18-006901
Filing Date
2018-02-09
Accepted
2018-02-09 14:45:06
Documents
1
Group Members
AUGUSTINE LAWLORCHRISTOPHER MIRABELLI, PH.D.HAROLD R. WERNERHEALTHCARE PARTNERS VIII, L.P.HEALTHCARE PARTNERS VIII, LLCJAMES H. CAVANAUGH, PH.D.JOHN W. LITTLECHILD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv485470_sc13d-a.htm SC 13D/A 148144
  Complete submission text file 0001144204-18-006901.txt   149943
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 18591032
SIC: 2834 Pharmaceutical Preparations

Mailing Address 44 NASSAU STREET PRINCETON NJ 08542
Business Address 44 NASSAU STREET PRINCETON NJ 08542 609-430-3913
HealthCare Ventures VIII, L.P. (Filed by) CIK: 0001358990 (see all company filings)

IRS No.: 841684310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A